Janux Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2020 | $9.2M | $16.2M | $7.8M |
| Jun 2021 | $12.0M | $396.8M | $251.6M |
| Sep 2021 | $14.3M | $391.1M | $39.4M |
| Dec 2021 | $13.5M | $379.8M | $35.6M |
| Mar 2022 | $12.5M | $368.6M | $55.1M |
| Jun 2022 | $41.6M | $385.4M | $58.4M |
| Sep 2022 | $44.2M | $375.8M | $64.8M |
| Dec 2022 | $43.3M | $364.0M | $51.4M |
| Mar 2023 | $41.7M | $353.0M | $30.4M |
| Jun 2023 | $42.0M | $341.5M | $33.7M |
| Sep 2023 | $37.9M | $386.9M | $17.2M |
| Dec 2023 | $36.1M | $380.4M | $19.2M |
| Mar 2024 | $33.2M | $689.0M | $212.8M |
| Jun 2024 | $33.7M | $691.4M | $14.7M |
| Sep 2024 | $38.9M | $695.0M | $26.8M |
| Dec 2024 | $38.7M | $1.06B | $430.6M |
| Mar 2025 | $38.3M | $1.05B | $73.7M |
| Jun 2025 | $41.7M | $1.03B | $52.4M |
| Sep 2025 | $48.2M | $1.02B | $48.4M |
| Dec 2025 | $44.7M | $1.00B | $52.3M |
| Mar 2026 | $86.7M | $1.03B | $51.8M |
| Jun 2026 | $79.7M | $1.01B | $27.8M |